Cape Investment Advisory’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.7K | Buy |
196
+8
| +4% | +$1.21K | 0.01% | 449 |
|
|
2025
Q1 | $28.3K | Buy |
188
+30
| +19% | +$4.52K | 0.01% | 423 |
|
|
2024
Q4 | $29.2K | Buy |
158
+20
| +14% | +$3.69K | 0.01% | 421 |
|
|
2024
Q3 | $27.2K | Sell |
138
-4
| -3% | -$788 | 0.01% | 408 |
|
|
2024
Q2 | $29.3K | Sell |
142
-51
| -26% | -$10.5K | 0.01% | 377 |
|
|
2024
Q1 | $52.3K | Buy |
193
+18
| +10% | +$4.88K | 0.02% | 303 |
|
|
2023
Q4 | $41.4K | Buy |
175
+2
| +1% | +$473 | 0.02% | 381 |
|
|
2023
Q3 | $33.9K | Hold |
173
| – | – | 0.02% | 357 |
|
|
2023
Q2 | $36.4K | Buy |
173
+136
| +368% | +$28.6K | 0.02% | 339 |
|
|
2023
Q1 | $7.47K | Buy |
+37
| New | +$7.47K | ﹤0.01% | 593 |
|